• English
    • Deutsch
  • English 
    • English
    • Deutsch
  • Login
View Item 
  •   Home
  • Universität Ulm / Medizin
  • Publikationsnachweise
  • View Item
  •   Home
  • Universität Ulm / Medizin
  • Publikationsnachweise
  • View Item
JavaScript is disabled for your browser. Some features of this site may not work without it.

Noncatalytic Bruton's tyrosine kinase activates PLC?(2) variants mediating ibrutinib resistance in human chronic lymphocytic leukemia cells

Erstveröffentlichung
2020
Authors
Wist, Martin
Meier, Laura
Gutman, Orit
Haas, Jennifer
Endres, Sascha
et al.
Wissenschaftlicher Artikel


Published in
Journal of Biological Chemistry ; 295 (2020), 17. - S. 5717-5736. - ISSN 0021-9258. - eISSN 1083-351X
Link to publication
https://dx.doi.org/10.1074/jbc.RA119.011946
Faculties
Medizinische Fakultät
Institutions
UKU. Institut für Pharmakologie und Toxikologie
Massenspektrometrie und Proteomics
UKU. Klinik für Innere Medizin III
UKU. Institut für Immunologie
Subject headings
[Free subject headings]: calcium | drug resistance | phospholipase C | phosphoinositide | inositol phospholipid | inositol phosphate | Rac (Rac GTPase) | tyrosine?protein kinase (tyrosine kinase) | B-cell receptor (BCR) | B-cell signaling | Bruton's tyrosine kinase (BTK) | chronic lymphocytic leukemia (CLL) | ibrutinib | PHOSPHOLIPASE-C-GAMMA | LIPID RAFTS | PHOSPHORYLATION SITES | C-BETA(2) ACTIVITY | CALCIUM-RELEASE | RECEPTOR | BTK | C-GAMMA(2) | BLNK | MUTATIONS
[DDC subject group]: DDC 570 / Life sciences

Metadata
Show full item record

Policy | kiz service OPARU | Contact Us
Impressum | Privacy statement
 

 

Advanced Search

Browse

All of OPARUCommunities & CollectionsPersonsInstitutionsPublication typesUlm SerialsDewey Decimal ClassesEU projects UlmDFG projects UlmOther projects Ulm

My Account

LoginRegister

Statistics

View Usage Statistics

Policy | kiz service OPARU | Contact Us
Impressum | Privacy statement